{"version":1,"type":"rich","provider_name":"Libsyn","provider_url":"https:\/\/www.libsyn.com","height":90,"width":600,"title":"Episode 359 - Raymond Benza, MD","description":"Dr. Raymond Benza is the Director for the Division of Cardiovascular Medicine at \u201cTHE\u201d Ohio State University. He has been in practice for more than 20 years. In this episode, Dr. Benza discusses GossamerBio\u2019s GB002 Phase 2 Study and explains what differentiates GB002 from other investigational drugs in development. Learn more about pulmonary hypertension trials at&amp;nbsp;www.phaware.global\/clinicaltrials. Never miss an episode with the&amp;nbsp;phaware\u00ae podcast app.&amp;nbsp;Follow us @phaware on Facebook, Twitter, Instagram, YouTube &amp;amp; Linkedin Engage for a cure:&amp;nbsp;www.phaware.global\/donate #phaware #ClinicalTrials @GossamerBio ","author_name":"I'm Aware That I'm Rare: the phaware\u00ae podcast","author_url":"http:\/\/phawarepodcast.libsyn.com\/podcast","html":"<iframe title=\"Libsyn Player\" style=\"border: none\" src=\"\/\/html5-player.libsyn.com\/embed\/episode\/id\/16961501\/height\/90\/theme\/custom\/thumbnail\/yes\/direction\/forward\/render-playlist\/no\/custom-color\/87A93A\/\" height=\"90\" width=\"600\" scrolling=\"no\"  allowfullscreen webkitallowfullscreen mozallowfullscreen oallowfullscreen msallowfullscreen><\/iframe>","thumbnail_url":"https:\/\/assets.libsyn.com\/secure\/content\/89413889"}